Tissue Regenix expects to breach revenue loan covenant; in talks with lender

Writer,

Regenerative medical devices company Tissue Regenix said it was in talks with loan provider MidCap Financial Trust after assessing that it would likely breach on one of loan's terms.

The terms of the loan credit facility and revolving credit facility included certain financial covenants, including a trailing 12-month revenue test.

That covenant was scheduled to be tested as at 31 October no later than the end of November.

'Based on the data available to the company the board are of the view that the company will fail this covenant test,' Tissue Regenix said.

'On that basis, the board has proactively engaged with MidCap Financial in respect of this potential breach and is currently in discussion in relation to the consequences of this.'

'These discussions are progressing well and the board is optimistic of being able to agree a solution with MidCap Financial.'

At 8:21am: (LON:TRX) Tissue Regenix Group PLC share price was -0.3p at 1.75p


Related content

Tissue Regenix kicks off manufacturing capacity expansion in Texas

Regenerative medical devices company Tissue Regenix said it had commenced the first phase of a planned manufacturing capacity expansion in San Antonio, Texas.

The expansion...

Fri, 24/07/2020 - 07:38


Tissue Regenix posts annual loss as expenses offset rising sales

Regenerative medical devices company Tissue Regenix posted a full-year loss, after rising sales were more than offset by expenses.

Pre-tax losses for the year through...

Fri, 05/06/2020 - 09:03


Tissue Regenix gets CE mark for OrthoPure XT technology

Medical devices company Tissue Regenix said its OrthoPure XT tissue regeneration product had obtained a CE Mark.

The mark has been awarded for revision of...

Mon, 01/06/2020 - 08:49


Tissue Regenix inks collaboration agreement for new tissue repair product

Regenerative medicine company Tissue Regenix said it had entered a manufacturing collaboration with a healthcare company to develop a new product line that addresses orthopaedic...

Mon, 11/05/2020 - 08:01


Tissue Regenix gets additional US government backed loan

Regenerative medical devices company Tissue Regenix said it had received a further $417k loan under the US government-backed Covid-19 business support scheme.

The funding was...

Mon, 20/04/2020 - 08:44